Retail Prices of Drugs: Clear Insights on New Pricing Changes
Retail prices of drugs are now fixed by India’s NPPA for 34 new medications, impacting consumers and pharmacies alike.
Exploring the Unseen and Unheard
Retail prices of drugs are now fixed by India’s NPPA for 34 new medications, impacting consumers and pharmacies alike.
Drug price controls are jeopardizing medical innovation and access to new treatments.
Drug price caps are being sought in Karnataka for broader affordability beyond just cancer medicines.
Lupin FDA approval marks a significant milestone in pharmaceutical advancements with Phytonadione Injectable Emulsion.
DCGI approval colchicine tablets brings new hope for patients seeking effective treatment options.
Cancer drug overpricing raises serious concerns about affordability and ethics in healthcare. Discover the shocking details.
Drug approval influence is under scrutiny as Democratic Party’s Choi Jae-sung faces accusations of misconduct.
AstraZeneca stock reaction shows significant gains following FDA’s accelerated approval for a new breast cancer treatment, boosting investor confidence.